LIN9 Antilichaam - N-terminalgebied: FITC (ARP50820_P050-FITC)

Lin-9 homolog (C. elegans)

TGS, BARA, TGS1, TGS2, Lin-9, BARPsv

286826

Q5TKA1-2

NP_775106

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit

The immunogen is a synthetic peptide directed towards the N terminal region of human LIN9

LIN9 belongs to the lin-9 family and acts as a tumor suppressor. It inhibits DNA synthesis. Its ability to inhibit oncogenic transformation is mediated through its association with RB1. LIN9 plays a role in the expression of genes required for the G1/S transition.

MYBL2; E2F4; RBL2; LIN54; LIN52; LIN37; RBL1; RBBP4; UBC; LIN9; TFDP2; TFDP1; MYBL1; RB1

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

0.5 mg/ml

Cow: 100%; Dog: 100%; Guinea Pig: 100%; Horse: 100%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

64kDa

Pilkinton, M., (2007) Oncogene 26 (54), 7535-7543

Wet Ice

558

LIN9

LIN9

Rabbit

Protein lin-9 homolog

NM_173083

SLQKTPVWKGRNTSSAVEMPFRNSKRSRLFSDEDDRQINTRSPKRNQRVA